All Relations between Atypical antipsychotics and Aripiprazole

Publication Sentence Publish Date Extraction Date Species
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kenji Hayashi, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Jun Nakamur. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. Journal of psychiatric research. vol 46. issue 6. 2012-10-17. PMID:22464338. the cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. 2012-10-17 2023-08-12 Not clear
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kenji Hayashi, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Jun Nakamur. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients. Journal of psychiatric research. vol 46. issue 6. 2012-10-17. PMID:22464338. we investigated the effects of the atypical antipsychotics risperidone, olanzapine, and aripiprazole on the cognitive functions of japanese patients with schizophrenia with respect to dosage amounts and dosing schedules. 2012-10-17 2023-08-12 Not clear
William Winlow, Louise Profit, Paul Chris. Aripiprazole: the evidence of its therapeutic impact in schizophrenia. Core evidence. vol 1. issue 4. 2012-10-02. PMID:22496680. the dopamine partial agonist aripiprazole is compared with this ideal and with conventional antipsychotics, such as haloperidol, and with atypical antipsychotics. 2012-10-02 2023-08-12 Not clear
Hyun-Ghang Jeong, Moon-Soo Lee, Hwa-Young Lee, Young-Hoon Ko, Changsu Han, Sook-Haeng Jo. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. International clinical psychopharmacology. vol 27. issue 4. 2012-09-27. PMID:22407277. our results suggest that sexual dysfunction in schizophrenia patients seems to improve after switching to aripiprazole from other atypical antipsychotics (risperiodone, amisulpride, or olanzapine). 2012-09-27 2023-08-12 human
Tomotaka Murotani, Tomoko Ishizuka, Yuka Isogawa, Michitaka Karashima, Atsushi Yamatodan. Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system. Neuropharmacology. vol 61. issue 1-2. 2012-04-17. PMID:21514311. some atypical antipsychotics like risperidone and aripiprazole are known to affect feeding behavior and to antagonize the serotonin (5-ht) receptor subtypes. 2012-04-17 2023-08-12 mouse
Takashi Ueda, Shinya Ugawa, Yusuke Ishida, Shoichi Shimad. Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors. European journal of pharmacology. vol 671. issue 1-3. 2012-03-01. PMID:21951966. although gm is far less potent at the dopamine receptor than aripiprazole at dopamine d(2l) receptors (ec(50)=4.4 μm for gm vs. ec(50)=56 nm for aripiprazole), gm and gm derivatives may comprise a new set of candidates for atypical antipsychotics. 2012-03-01 2023-08-12 Not clear
Takahiro A Kato, Akira Monji, Keiji Yasukawa, Yoshito Mizoguchi, Hideki Horikawa, Yoshihiro Seki, Sadayuki Hashioka, Youn-Hee Han, Mina Kasai, Noriyuki Sonoda, Eiichi Hirata, Yasutaka Maeda, Toyoshi Inoguchi, Hideo Utsumi, Shigenobu Kanb. Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia. Schizophrenia research. vol 129. issue 2-3. 2011-10-13. PMID:21497059. we previously demonstrated that atypical antipsychotics including aripiprazole significantly inhibited the release of nitric oxide and proinflammatory cytokines from interferon-γ-stimulated microglia in vitro. 2011-10-13 2023-08-12 Not clear
Haya Ascher-Svanum, Michael D Stensland, Xiaomei Peng, Douglas E Faries, Virginia L Stauffer, Olawale O Osuntokun, John M Kan. Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia. Current medical research and opinion. vol 27. issue 1. 2011-04-01. PMID:21110749. information about the cost-effectiveness of aripiprazole relative to other atypical antipsychotics in the treatment of patients with schizophrenia is limited. 2011-04-01 2023-08-12 Not clear
Faruk Ugu. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder. General hospital psychiatry. vol 32. issue 5. 2011-01-21. PMID:20851277. data on the efficacy of aripiprazole in obsessive-compulsive disorder (ocd), compared to data on the efficacy of other atypical antipsychotics, are inadequate. 2011-01-21 2023-08-12 Not clear
Eiji Kirin. Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report. Clinical schizophrenia & related psychoses. vol 4. issue 3. 2010-11-30. PMID:20880829. aripiprazole, which has a unique pharmacological mechanism of action distinct from other atypical antipsychotics and an excellent safety profile, may be effective in the treatment of some schizophrenic patients with stupor, which sometimes carries a risk of physical debilitation and requires special attention due to the risk of adverse drug reactions. 2010-11-30 2023-08-12 Not clear
William V Bobo, Richard C Shelto. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression. Expert review of neurotherapeutics. vol 10. issue 5. 2010-08-11. PMID:20420487. three atypical antipsychotics (aripiprazole, quetiapine and olanzapine) have received regulatory approval for adjunctive use with antidepressants for treatment-resistant major depression (trd) in adults. 2010-08-11 2023-08-12 Not clear
Janelle Guirguis-Blak. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia. American family physician. vol 81. issue 11. 2010-06-22. PMID:20521753. aripiprazole vs. other atypical antipsychotics for schizophrenia. 2010-06-22 2023-08-12 Not clear
Arnim Quante, Sara Zeugmann, Alexander Luborzewski, Nicole Schommer, Jens Langosch, Christoph Born, Ion Anghelescu, Juergen Wol. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Human psychopharmacology. vol 25. issue 2. 2010-06-14. PMID:20196183. the use of atypical antipsychotics (aaps) for the treatment of unipolar and bipolar depression has been more and more frequently evaluated, and aripiprazole showed positive effects in the treatment of unipolar depression. 2010-06-14 2023-08-12 Not clear
Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Jeong-Hoon Lee, Yo-Han Lee, Su-Jin Yang, Jin-Sang Yoo. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. Clinical neuropharmacology. vol 32. issue 5. 2010-06-01. PMID:19620849. effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. 2010-06-01 2023-08-12 Not clear
Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Jeong-Hoon Lee, Yo-Han Lee, Su-Jin Yang, Jin-Sang Yoo. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. Clinical neuropharmacology. vol 32. issue 5. 2010-06-01. PMID:19620849. to examine changes in cognitive function and clinical features after a switch from atypical antipsychotics to aripiprazole in patients with schizophrenia. 2010-06-01 2023-08-12 Not clear
Katja Komossa, Christine Rummel-Kluge, Franziska Schmid, Heike Hunger, Sandra Schwarz, Hany George G El-Sayeh, Werner Kissling, Stefan Leuch. Aripiprazole versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews. issue 4. 2010-01-27. PMID:19821375. aripiprazole versus other atypical antipsychotics for schizophrenia. 2010-01-27 2023-08-12 Not clear
John W Newcomer, Jonathan M Meyer, Ross A Baker, James M Eudicone, Andrei Pikalov, Estelle Vester-Blokland, Robert D McQuade, David T Crandall, William H Carson, Ronald N Marcus, Gilbert L'italie. Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine. Schizophrenia research. vol 106. issue 2-3. 2009-06-10. PMID:18973991. this post-hoc analysis assessed changes in these parameters during treatment with the atypical antipsychotics olanzapine or aripiprazole using pooled data from three randomized, long-term clinical studies in patients with schizophrenia. 2009-06-10 2023-08-12 Not clear
Yuji Odagak. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Current drug safety. vol 4. issue 1. 2009-03-31. PMID:19149529. some of atypical antipsychotics, i.e., perospirone, aripiprazole, ziprasidone, clozapine, and quetiapine, have been shown to behave as partial agonists at 5-ht1a receptors, providing direct evidence that these atypical antipsychotics are serotomimetic per se. 2009-03-31 2023-08-12 Not clear
Ronette L Kolotkin, Patricia K Corey-Lisle, Ross D Crosby, Hong J Kan, Robert D McQuad. Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care. European psychiatry : the journal of the Association of European Psychiatrists. vol 23. issue 8. 2009-03-05. PMID:18374544. we examined changes in weight and weight-related quality of life among community patients with schizophrenia treated with aripiprazole (ari) versus standard of care (soc), consisting of other marketed atypical antipsychotics (olanzapine, quetiapine, and risperidone). 2009-03-05 2023-08-12 Not clear
Subramanian Madhusoodanan, Payal Sha. Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole. Clinical interventions in aging. vol 3. issue 3. 2008-12-09. PMID:18982919. further studies comparing the efficacy and tolerability of aripiprazole vs other atypical antipsychotics in dementia are needed. 2008-12-09 2023-08-12 Not clear